scispace - formally typeset
E

Emma T van der Westhuizen

Researcher at Monash University

Publications -  35
Citations -  992

Emma T van der Westhuizen is an academic researcher from Monash University. The author has contributed to research in topics: Allosteric regulation & Muscarinic acetylcholine receptor. The author has an hindex of 12, co-authored 27 publications receiving 805 citations. Previous affiliations of Emma T van der Westhuizen include Monash University, Clayton campus & Université de Montréal.

Papers
More filters
Journal ArticleDOI

Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy.

TL;DR: A higher level of ligand texture is demonstrated than previously anticipated, opening perspectives for the establishment of pluridimensional correlations between signaling profiles, drug classification, therapeutic efficacy, and safety.
Journal ArticleDOI

Endogenous Allosteric Modulators of G Protein–Coupled Receptors

TL;DR: The increasing identification of allosteric modulator lipids, inflammatory peptides, and G PCR-targeted autoantibodies indicates that disease context plays an important role in the generation of putative endogenous GPCR modulators.
Journal ArticleDOI

Impedance Responses Reveal β2-Adrenergic Receptor Signaling Pluridimensionality and Allow Classification of Ligands with Distinct Signaling Profiles

TL;DR: It is demonstrated that a single label-free assay based on cellular impedance provides a real-time integration of multiple signaling events engaged upon GPCR activation, indicating that the pluridimensionality of G PCR signaling can be captured using integrative approaches to provide a comprehensive readout of drug activity.
Journal ArticleDOI

The Relaxin Family Peptide Receptor 3 Activates Extracellular Signal-Regulated Kinase 1/2 through a Protein Kinase C-Dependent Mechanism

TL;DR: It is identified that RXFP3 stably expressed in Chinese hamster ovary (CHO)-K1 and human embryonic kidney (HEK-RXFP3) cells activates extracellular signal-regulated kinase (ERK) 1/2 when stimulated with H3 relaxin and an H3 Relaxin B-chain (dimer) peptide.